Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)

Argentina flag Argentina · Delayed Price · Currency is ARS
1,630.00
+15.00 (0.93%)
May 22, 2026, 4:59 PM BRT
Market Cap131.22B +14.8%
Revenue (ttm)119.64B +23.8%
Net Income16.73B -9.5%
EPSn/a
Shares Out80.75M
PE Ratio7.84
Forward PEn/a
Dividend26.89 (1.65%)
Ex-Dividend DateMay 14, 2026
Volume4,298
Average Volume5,203
Open1,640.00
Previous Close1,615.00
Day's Range1,575.00 - 1,690.00
52-Week Range945.00 - 2,300.00
Beta-0.60
RSI50.18
Earnings DateMay 21, 2026

About BCBA:RICH

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnot... [Read more]

Sector Healthcare
Founded 1959
Employees 620
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol RICH
Full Company Profile

Financial Performance

In 2025, BCBA:RICH's revenue was 126.73 billion, an increase of 4.95% compared to the previous year's 120.75 billion. Earnings were 3.09 billion, a decrease of -90.16%.

Financial Statements